FUJIFILM Diosynth Biotechnologies, a Texas A&M University System subcontractor, will mass produce vaccines as part of an agreement between the federal government and the Center for Innovation in Advanced Development and Manufacturing.
Texas A&M experts discuss what we can expect if and when a COVID-19 vaccine becomes available, how anti-vaxxers could affect outcomes for everyone else.
Scientists are recruiting hundreds of medical workers to test the existing vaccine's ability to mitigate the effects of the illness. Results are expected within six months.
A child in Romania, on June 6, 2018, receives vaccination after a measles outbreak has sickened hundreds of children. Health officials say the outbreak is serious because of low vaccination rates. (Olimpiu Gheorghiu/AP Photos) By Timothy Callaghan, Texas A&M University; Matthew Motta, University of Pennsylvania; and Steven Sylvester, Utah Valley University, for The…